- Announcement of Comprehensive Business Alliance（PDF）
- Launch of Distribution of GAP and GAP-screener- the Gaze Analyzing Perimeters（PDF）
- Launch of Distribution of the M22 IPL Model（PDF）
- Launch of Distribution of Medical Devices（PDF）
- Launch of a New Treatment for “Ranibizumab BS Intravitreal Injection Kit 10 mg/mL ‘Senju’”（PDF）
- Ophthalmic VEGF Inhibitor Acquisition of Marketing Approval for “Ranibizumab BS Intravitreal Injection Kit 10 mg/mL ‘Senju’”（PDF）
- Senju and Otsuka Launch a New Treatment for Glaucoma and Ocular Hypertension - AIBETA® Combination Ophthalmic Solution（PDF）
- Launch of Neuroptika, Inc.（PDF）
- Announcement of co-promotion of new glaucoma treatment（PDF）
- License Agreement to Development and Commercialize Azithromycin Ophthalmic Solution Using DuraSite® in Japan
- Collaboration License Agreement for the Development and Commercialization of Integrin Peptide Therapy
- To be released on May 11, 2012: “AIPHAGAN® Ophthalmic Solution 0.1%”for the treatment of Glaucoma / Ocular Hypertension （PDF）
- The approval of 『BRONUCK ®』 （bromfenac sodium hydrate ophthalmic solution）as an import drug in China（PDF）